rs61735621
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_006206.6(PDGFRA):c.1280C>T(p.Ser427Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000998 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S427P) has been classified as Uncertain significance.
Frequency
Consequence
NM_006206.6 missense
Scores
Clinical Significance
Conservation
Publications
- gastrointestinal stromal tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- polyps, multiple and recurrent inflammatory fibroid, gastrointestinalInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P
- congenital heart diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
- isolated cleft palateInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PDGFRA | ENST00000257290.10 | c.1280C>T | p.Ser427Leu | missense_variant | Exon 9 of 23 | 1 | NM_006206.6 | ENSP00000257290.5 | ||
| PDGFRA | ENST00000509092.5 | n.1098C>T | non_coding_transcript_exon_variant | Exon 8 of 15 | 1 | |||||
| PDGFRA | ENST00000509490.5 | n.1280C>T | non_coding_transcript_exon_variant | Exon 9 of 18 | 1 | ENSP00000424218.1 | ||||
| ENSG00000282278 | ENST00000507166.5 | c.1018-2489C>T | intron_variant | Intron 12 of 23 | 2 | ENSP00000423325.1 |
Frequencies
GnomAD3 genomes AF: 0.000533 AC: 81AN: 152070Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000159 AC: 40AN: 251334 AF XY: 0.000118 show subpopulations
GnomAD4 exome AF: 0.0000547 AC: 80AN: 1461814Hom.: 0 Cov.: 32 AF XY: 0.0000371 AC XY: 27AN XY: 727222 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000532 AC: 81AN: 152188Hom.: 0 Cov.: 31 AF XY: 0.000551 AC XY: 41AN XY: 74392 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1Benign:1
- -
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal Uncertain:1
The PDGFRA c.1280C>T (p.Ser427Leu) missense change has a maximum subpopulation frequency of 0.21% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). The in silico tool REVEL is inconclusive about a pathogenic or benign effect of this variant on protein function, and to our knowledge functional studies have not been performed. To our knowledge, this variant has not been reported in individuals with PDGFRA-associated tumors. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Idiopathic hypereosinophilic syndrome Uncertain:1
- -
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
PDGFRA-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Gastrointestinal stromal tumor Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at